Ireland
--:--IST
Latest
Clinical Trials in France / NCT04163315
Active, not recruiting Not applicable

Multimodal Connectome Study of Brain Tumor-operated Patients

NCT04163315 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2019-12-12
Last updated
2025-12-03

Condition(s) studied

Tumor, Brain

Investigational drug(s) / intervention(s)

dMRI, fMRI and electrocorticography

dMRI, fMRI and electrocorticography: Patients included in the study will perform the pre-operative MRI (fMRI and fMRI) with a specific High Resolution Angular Diffusion (HARDI) sequence and a functional rest sequence. The additional scan time for this specific sequence is approximately 25 minutes, with no foreseeable negative impact on the patient

Study summary

In this pilot study, the investigators propose a multimodal evaluation of the brain connectivity of brain tumor patients, in order to better understand the effects induced by focal lesions on brain structure and function, as well as brain plasticity mechanisms that may occur in such condition. The investigators aim at drawing a multimodal brain connectivity map of focally brain-damaged patients, with a view to improve onco-functional neurosurgical practices.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients with brain tumor for removal * Age \> 18 years * Informed patient consent * Membership of social security scheme Exclusion Criteria: * Contraindication to MRI * Any subject with vascular stent implanted less than 6 weeks prior to the exam; * Any subject carrying an intraocular or intracranial ferromagnetic foreign object close to nerve structures; * Any subject carrying biomedical equipment such as a cardiac, neuronal or sensory pacemaker (cochlear implant) or a ventricular bypass valve without medical and paramedical supervision trained in the performance of MRI in these subjects; * Presence of more than one brain tumor * Refusal of patient participation * Pregnant or nursing women. A urinary pregnancy test will be conducted for women of childbearing age. The results will be communicated to the patient by a doctor of her choice. * Person staying in a health or social establishment * Person in emergency situation * Vulnerable patient: deprived of liberty, guardianship, curators, or safeguarding of justice

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
CHU de Nice Nice CHU de NICE

More Centre Hospitalier Universitaire de Nice trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04163315 on ClinicalTrials.gov ↗ ← All trials in France